Altered pathways and targeted therapy in double hit lymphoma

Abstract High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6, usually referred to as double hit lymphoma (DHL), is an aggressive hematological malignance with distinct genetic features and poor clinical prognosis. Current standard chemoimmunotherapy fails to confer satisfyi...

詳細記述

書誌詳細

主要な著者:	Yuxin Zhuang, Jinxin Che, Meijuan Wu, Yu Guo, Yongjin Xu, Xiaowu Dong, Haiyan Yang
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2022-03-01
シリーズ:	Journal of Hematology & Oncology
主題:	Double hit lymphoma Diffuse large B-cell lymphoma Genetic alterations Targeted therapy Chemotherapy
オンライン･アクセス:	https://doi.org/10.1186/s13045-022-01249-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!